We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Widens Remdesivir’s EUA to Include Mild and Moderate COVID-19 Patients
FDA Widens Remdesivir’s EUA to Include Mild and Moderate COVID-19 Patients
The FDA announced late Friday that it has decided to expand its Emergency Use Authorization (EUA) for Gilead Sciences’ remdesivir, allowing its use in patients with mild or moderate COVID-19 infections.